TEST ID HIAAR 5-Hydroxyindoleacetic Acid, Random, Urine
Reporting Name
5-HIAA, Random, USpecimen Type
UrineOrdering Guidance
This test uses a random urine collection to assess 5-hydroxyindoleacetic acid concentrations. If a 24-hour urine collection is preferred, order HIAA / 5-Hydroxyindoleacetic Acid, 24 Hour, Urine.
Necessary Information
Patient's age and sex are required.
Specimen Required
Patient Preparation:
1. Some medications could interfere with test results. If medically feasible, for 48 hours before specimen collection, patient should not take the following medications:
-Acetaminophen (Tylenol or generic versions)
-Tryptophan containing supplements
2. For 48 hours prior to the urine collection, the patient should limit the following to one serving per day:
-Fruits
-Vegetables
-Nuts
-Caffeinated beverages or foods
Supplies: Urine Tubes, 10 mL (T068)
Container/Tube: Plastic, 10-mL urine tube
Specimen Volume: 5 mL
Collection Instructions:
1. Collect a random urine specimen.
2. Store and send refrigerate
Specimen Minimum Volume
2 mL
Specimen Stability Information
| Specimen Type | Temperature | Time |
|---|---|---|
| Urine | Refrigerated (preferred) | 56 days |
| Frozen | 365 days |
Method Name
Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS)
Reject Due To
All specimens will be evaluated at Mayo Clinic Laboratories for test suitability.Reference Values
99th percentile cutoff
|
Age |
Female |
Male |
|
≤23 months |
≤17.53 |
≤16.42 |
|
24-35 months |
≤17.07 |
≤15.96 |
|
3 years |
≤16.70 |
≤15.60 |
|
4 years |
≤16.03 |
≤14.93 |
|
5 years |
≤15.26 |
≤14.17 |
|
6 years |
≤14.40 |
≤13.34 |
|
7 years |
≤13.47 |
≤12.43 |
|
8 years |
≤12.52 |
≤11.52 |
|
9 years |
≤11.58 |
≤10.63 |
|
10 years |
≤10.67 |
≤9.79 |
|
11 years |
≤9.81 |
≤9.00 |
|
12 years |
≤9.02 |
≤8.29 |
|
13 years |
≤8.32 |
≤7.65 |
|
14 years |
≤7.70 |
≤7.08 |
|
15 years |
≤7.16 |
≤6.59 |
|
16 years |
≤6.72 |
≤6.15 |
|
17 years |
≤6.36 |
≤5.78 |
|
18 years |
≤6.08 |
≤5.45 |
|
19 years |
≤5.88 |
≤5.17 |
|
20 years |
≤5.73 |
≤4.93 |
|
21 years |
≤5.64 |
≤4.73 |
|
22 years |
≤5.59 |
≤4.55 |
|
23 years |
≤5.57 |
≤4.40 |
|
24 years |
≤5.57 |
≤4.28 |
|
25 years |
≤5.58 |
≤4.19 |
|
26 years |
≤5.61 |
≤4.11 |
|
27 years |
≤5.64 |
≤4.06 |
|
28 years |
≤5.67 |
≤4.03 |
|
29 years |
≤5.70 |
≤4.02 |
|
30 years |
≤5.72 |
≤4.01 |
|
31 years |
≤5.75 |
≤4.02 |
|
32 years |
≤5.77 |
≤4.03 |
|
33 years |
≤5.78 |
≤4.05 |
|
34 years |
≤5.79 |
≤4.06 |
|
35 years |
≤5.80 |
≤4.08 |
|
36 years |
≤5.80 |
≤4.09 |
|
37 years |
≤5.80 |
≤4.11 |
|
38 years |
≤5.80 |
≤4.12 |
|
39 years |
≤5.81 |
≤4.14 |
|
40 years |
≤5.82 |
≤4.17 |
|
41 years |
≤5.85 |
≤4.22 |
|
42 years |
≤5.89 |
≤4.27 |
|
43 years |
≤5.95 |
≤4.35 |
|
44 years |
≤6.04 |
≤4.43 |
|
45 years |
≤6.14 |
≤4.53 |
|
46 years |
≤6.26 |
≤4.63 |
|
47 years |
≤6.40 |
≤4.75 |
|
48 years |
≤6.55 |
≤4.86 |
|
49 years |
≤6.71 |
≤4.99 |
|
50 years |
≤6.86 |
≤5.11 |
|
51 years |
≤7.01 |
≤5.24 |
|
52 years |
≤7.15 |
≤5.37 |
|
53 years |
≤7.29 |
≤5.51 |
|
54 years |
≤7.41 |
≤5.64 |
|
55 years |
≤7.52 |
≤5.78 |
|
56 years |
≤7.62 |
≤5.91 |
|
57 years |
≤7.71 |
≤6.05 |
|
58 years |
≤7.80 |
≤6.17 |
|
59 years |
≤7.88 |
≤6.29 |
|
60 years |
≤7.95 |
≤6.41 |
|
61 years |
≤8.02 |
≤6.51 |
|
62 years |
≤8.09 |
≤6.60 |
|
63 years |
≤8.15 |
≤6.69 |
|
64 years |
≤8.21 |
≤6.76 |
|
65 years |
≤8.28 |
≤6.82 |
|
66 years |
≤8.34 |
≤6.88 |
|
67 years |
≤8.40 |
≤6.93 |
|
68 years |
≤8.46 |
≤6.97 |
|
69 years |
≤8.52 |
≤7.00 |
|
70 years |
≤8.58 |
≤7.03 |
|
71 years |
≤8.65 |
≤7.06 |
|
72 years |
≤8.71 |
≤7.08 |
|
73 years |
≤8.77 |
≤7.10 |
|
74 years |
≤8.82 |
≤7.11 |
|
75 years |
≤8.86 |
≤7.11 |
|
76 years |
≤8.90 |
≤7.11 |
|
77 years |
≤8.92 |
≤7.10 |
|
78 years |
≤8.93 |
≤7.09 |
|
79 years |
≤8.93 |
≤7.07 |
|
80 years |
≤8.92 |
≤7.05 |
|
81 years |
≤8.90 |
≤7.02 |
|
82 years |
≤8.88 |
≤7.00 |
|
83 years |
≤8.86 |
≤6.98 |
|
84 years |
≤8.85 |
≤6.97 |
|
85 years |
≤8.84 |
≤6.95 |
|
86 years |
≤8.84 |
≤6.94 |
|
87 years |
≤8.84 |
≤6.94 |
|
88 years |
≤8.84 |
≤6.94 |
|
>or= 89 years |
≤8.85 |
≤6.93 |
Day(s) Performed
Monday through Friday
Report Available
2 to 4 daysSpecimen Retention Time
7 daysPerforming Laboratory
Mayo Clinic Laboratories in Rochester
CPT Code Information
83497
Useful For
Biochemical diagnosis and monitoring of intestinal carcinoid syndrome using random urine specimens
Clinical Information
5-Hydroxyindoleacetic acid (5-HIAA) is the major metabolite of serotonin and is excreted in the urine. Intestinal carcinoid tumors, along with neuroendocrine tumors, can produce excess amounts of 5-HIAA and serotonin, especially in individuals with carcinoid syndrome. Carcinoid syndrome is characterized by carcinoid tumors, flushing, heart disease, and hepatomegaly.
Measurement of 5-HIAA in a random urine specimen can diagnose carcinoid disease with a high specificity.
Cautions
Intake of food with a high content of serotonin (avocados, dates, eggplant, all fruit [including bananas, cantaloupe, grapefruit, kiwifruit, melons, pineapple, plantains, plums], all nuts [including hickory nuts, butternuts, pecans, walnuts], and tomatoes and tomato products) within 48 hours of the urine collection could result in falsely elevated 5-hydroxyindoleacetic acid (5-HIAA) excretion.
Numerous drugs affect the excretion of 5-HIAA by different mechanisms, including increased serotonin synthesis, metabolism, and release and inhibition of uptake. The following medications can interfere with 5-HIAA results.
-Acetaminophen (Tylenol or generic versions)
-Tryptophan containing supplements
Patient should also avoid caffeinated beverages, such as tea and coffee, or caffeinated foods, such as dark chocolate, for 48 hours before and during specimen collection.
Method Description
5-Hydroxyindoleacetic acid (5-HIAA) is measured by solid phase extraction of an aliquot from a random urine collection and liquid chromatography tandem mass spectrometry analysis. 5-HIAA is quantitated using a custom synthesized stable isotope labeled internal standard (d6-5-HIAA) from calibration over a concentration range 0.5 to 150 mg/L.(Kroll CA, Magera MJ, Helgeson JK, Matern D, Rinaldo P. Liquid chromatographic-tandem mass spectrometric method for the determination of 5-hydroxyindole-3-acetic acid in urine. Clin Chem. 2002;48[11]:2049-2051; Calanchini M, Tadman M, Krogh J, Fabbri A, Grossman A, Shine B. Measurement of urinary 5-HIAA: correlation between spot versus 24-h urine collection. Endocr Connect. 2019;8(8):1082-1088)